plasma-derived human alpha-1 antitrypsin (Liminal BioSciences/Hematech)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameplasma-derived human alpha-1 antitrypsin (Liminal BioSciences/Hematech)
Drug Alias Nameplasma-derived human alpha-1 antitrypsin (ProMetic/Hematech)alpha-1-antitrypsin human
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAlpha-1-antiproteinase modulators
TargetsAlpha-1-antiproteinase
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLiminal Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHematech Biotherapeutics IncLiminal Biosciences Inc
Active IndicationsN/A
Inactive Indicationsalpha 1-Antitrypsin Deficiency

Other Information

ATC CodeN/A
Related LinksN/A